A PHASE 1, OPEN-LABEL STUDY TO EVALUATE THE PHARMACOKINETICS, SAFETY, AND TOLERABILITY OF ORALLY ADMINISTERED NIRMATRELVIR/RITONAVIR IN PREGNANT WOMEN WITH MILD-TOMODERATE COVID-19

  • Saade, George (PI)

Project: Other project

Project Details

StatusActive
Effective start/end date5/26/22 → 5/25/27

Funding

  • Pfizer, Inc.: $10,125.00